These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18283333)

  • 1. Comparison of expression profiles of metastatic versus primary mammary tumors in MMTV-Wnt-1 and MMTV-Neu transgenic mice.
    Huang S; Chen Y; Podsypanina K; Li Y
    Neoplasia; 2008 Feb; 10(2):118-24. PubMed ID: 18283333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt-1 is dominant over neu in specifying mammary tumor expression profiles.
    Huang S; Podsypanina K; Chen Y; Cai W; Tsimelzon A; Hilsenbeck S; Li Y
    Technol Cancer Res Treat; 2006 Dec; 5(6):565-71. PubMed ID: 17121432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.
    Huang S; Li Y; Chen Y; Podsypanina K; Chamorro M; Olshen AB; Desai KV; Tann A; Petersen D; Green JE; Varmus HE
    Genome Biol; 2005; 6(10):R84. PubMed ID: 16207355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.
    Oloumi A; Maidan M; Lock FE; Tearle H; McKinney S; Muller WJ; Aparicio SA; Dedhar S
    Breast Cancer Res; 2010; 12(3):R38. PubMed ID: 20565980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype.
    Podsypanina K; Li Y; Varmus HE
    BMC Med; 2004 Jun; 2():24. PubMed ID: 15198801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice.
    Ritland SR; Rowse GJ; Chang Y; Gendler SJ
    Cancer Res; 1997 Aug; 57(16):3520-5. PubMed ID: 9270023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenge with mammary tumor cells expressing MHC class II and CD80 prevents the development of spontaneously arising tumors in MMTV-neu transgenic mice.
    Jabrane-Ferrat N; Campbell MJ; Esserman LJ; Peterlin BM
    Cancer Gene Ther; 2006 Nov; 13(11):1002-10. PubMed ID: 16841083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.
    Liu JC; Deng T; Lehal RS; Kim J; Zacksenhaus E
    Cancer Res; 2007 Sep; 67(18):8671-81. PubMed ID: 17875707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Limb-Bud-and-Heart (LBH) attenuates mammary hyperplasia and tumor development in MMTV-Wnt1 transgenic mice.
    Ashad-Bishop K; Garikapati K; Lindley LE; Jorda M; Briegel KJ
    Biochem Biophys Res Commun; 2019 Jan; 508(2):536-542. PubMed ID: 30509497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas.
    Schroeder JA; Adriance MC; McConnell EJ; Thompson MC; Pockaj B; Gendler SJ
    J Biol Chem; 2002 Jun; 277(25):22692-8. PubMed ID: 11950845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARalpha agonist AM580.
    Lu Y; Bertran S; Samuels TA; Mira-y-Lopez R; Farias EF
    Oncogene; 2010 Jun; 29(25):3665-76. PubMed ID: 20453882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
    Landis MD; Seachrist DD; Montañez-Wiscovich ME; Danielpour D; Keri RA
    Oncogene; 2005 Aug; 24(33):5173-90. PubMed ID: 15897883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Notch1 in the development of mouse mammary tumors.
    Diévart A; Beaulieu N; Jolicoeur P
    Oncogene; 1999 Oct; 18(44):5973-81. PubMed ID: 10557086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice.
    Strumane K; Rygiel T; van der Valk M; Collard JG
    J Cancer Res Clin Oncol; 2009 Jan; 135(1):69-80. PubMed ID: 18592271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer.
    Taneja P; Frazier DP; Kendig RD; Maglic D; Sugiyama T; Kai F; Taneja NK; Inoue K
    Expert Rev Mol Diagn; 2009 Jul; 9(5):423-40. PubMed ID: 19580428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice.
    Watanabe K; Fallahi M; Dai X
    Oncogene; 2014 Jan; 33(5):632-42. PubMed ID: 23334328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMTV-Wnt1 and -DeltaN89beta-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors.
    Teissedre B; Pinderhughes A; Incassati A; Hatsell SJ; Hiremath M; Cowin P
    PLoS One; 2009; 4(2):e4537. PubMed ID: 19225568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.
    Menezes ME; Shen XN; Das SK; Emdad L; Guo C; Yuan F; Li YJ; Archer MC; Zacksenhaus E; Windle JJ; Subler MA; Ben-David Y; Sarkar D; Wang XY; Fisher PB
    Oncotarget; 2015 Nov; 6(35):36928-42. PubMed ID: 26474456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.
    Qiu TH; Chandramouli GV; Hunter KW; Alkharouf NW; Green JE; Liu ET
    Cancer Res; 2004 Sep; 64(17):5973-81. PubMed ID: 15342376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention activity of dipyridamole in the MMTV-PyMT transgenic mouse model of breast cancer.
    Wang C; Schwab LP; Fan M; Seagroves TN; Buolamwini JK
    Cancer Prev Res (Phila); 2013 May; 6(5):437-47. PubMed ID: 23447563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.